A PSA test in midlife could help to identify men at low risk of prostate cancer, supporting screening strategies and reducing overdiagnosis.
Laboratory reference ranges reflect methods, populations, and policies, and experienced clinicians interpret them in context rather than applying fixed cutoffs theoretically.
The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men ...
It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results